Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine TumorsJonathan Strosberg, Eric P. Krenning, Ghassan El‐Haddad et al.|New England Journal of Medicine|2017Cited by 3.2k
Population-Based Study of Islet Cell CarcinomaJames C. Yao, Douglas B. Evans|Annals of Surgical Oncology|2007Cited by 338
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 studyArvind Dasari, Cathy Eng, Violaine Randrian et al.|The Lancet|2023Cited by 319
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trialAhmed O. Kaseb, Padmanee Sharma, Elshad Hasanov et al.|The Lancet. Gastroenterology & hepatology|2022Cited by 255
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNAAhmed O. Kaseb, Razelle Kurzrock, Nora Sánchez et al.|Clinical Cancer Research|2019Cited by 76